Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma
暂无分享,去创建一个
Yan Lin | R. Liang | Rong-yun Mai | Xing Gao | Lu Lu | Julu Huang | Minchao Tang | Jiazhou Ye | Tianzhun Wu | Xi Huang | Shilin Huang | Wenfeng Luo | Dandan Zeng | Shizhou Li | Yongqiang Li | Cheng Lu | Can zeng | Hongyang huang | Kaixiang mo | Min luo | Mingzhi xie | Shan Wang
[1] Ying Chai,et al. In situ tissue profile of rat trigeminal nerve in trigeminal neuralgia using spatial transcriptome sequencing , 2024, International journal of surgery.
[2] Q. Liao,et al. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential , 2023, Experimental & molecular medicine.
[3] Li-li Zheng,et al. Angiogenic signaling pathways and anti-angiogenic therapy for cancer , 2023, Signal transduction and targeted therapy.
[4] Cong Yu,et al. Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human injured brain , 2023, Cell reports. Medicine.
[5] Lei Zhang,et al. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease , 2023, Frontiers in Immunology.
[6] H. Tzeng,et al. Tumor Vasculature as an Emerging Pharmacological Target to Promote Anti-Tumor Immunity , 2023, International journal of molecular sciences.
[7] Xiaojing Ma,et al. Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability , 2023, Blood Advances.
[8] S. Ohnishi,et al. Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma , 2023, Cancers.
[9] Lemin Zheng,et al. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies , 2023, Cancer biology & medicine.
[10] A. Kater,et al. JAK–STAT signalling shapes the NF‐κB response in CLL towards venetoclax sensitivity or resistance via Bcl‐XL , 2022, Molecular oncology.
[11] Cheng Cao,et al. GP73 blockade alleviates abnormal glucose homeostasis in diabetic mice. , 2022, Journal of Molecular Endocrinology.
[12] Chenfei Wang,et al. Evaluation of cell-cell interaction methods by integrating single-cell RNA sequencing data with spatial information , 2022, Genome Biology.
[13] Maohui Luo,et al. Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma , 2022, Oxidative medicine and cellular longevity.
[14] Evan Z. Macosko,et al. Cell type-specific inference of differential expression in spatial transcriptomics , 2022, Nature Methods.
[15] L. Qin,et al. Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma. , 2022, Cell reports.
[16] M. Ryten,et al. ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2 , 2022, bioRxiv.
[17] D. Hanahan. Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.
[18] Hongchuan Jin,et al. Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer , 2021, Frontiers in Oncology.
[19] L. Qin,et al. GOLM1 exacerbates CD8+ T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages , 2021, Signal Transduction and Targeted Therapy.
[20] Qing Wang,et al. GOLM1 Drives Colorectal Cancer Metastasis by Regulating Myeloid-derived Suppressor Cells , 2021, Journal of Cancer.
[21] S. Zahler,et al. Mechanical Aspects of Angiogenesis , 2021, Cancers.
[22] Sohail M. Noman,et al. Microbiomes and Resistomes in Biopsy Tissue and Intestinal Lavage Fluid of Colorectal Cancer , 2021, Frontiers in Cell and Developmental Biology.
[23] C. Diaconu,et al. Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment , 2021, Frontiers in Cell and Developmental Biology.
[24] M. Safa,et al. MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies , 2021, Journal of Hematology & Oncology.
[25] Midie Xu,et al. FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer , 2021, Oncogene.
[26] Jinyun Dong,et al. Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation. , 2021, Journal of medicinal chemistry.
[27] Qian Zhang,et al. C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma. , 2021, Biochemical pharmacology.
[28] Z. Qiu,et al. Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis , 2021, World journal of gastroenterology.
[29] Qifeng Yang,et al. LINC01977 Promotes Breast Cancer Progression and Chemoresistance to Doxorubicin by Targeting miR-212-3p/GOLM1 Axis , 2021, Frontiers in Oncology.
[30] Xianqun Fan,et al. Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma , 2021, Genome biology.
[31] Yuquan Wei,et al. Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment , 2021, Cell proliferation.
[32] E. Leung,et al. The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy , 2021, Cell death discovery.
[33] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[34] D. Ribatti,et al. Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma. , 2021, The American journal of pathology.
[35] W. Qiu,et al. Correction: Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer , 2020, Cell Death and Disease.
[36] Q. Ye,et al. GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma. , 2020, American journal of cancer research.
[37] Y. Wan,et al. Golgi protein 73, hepatocellular carcinoma and other types of cancers , 2020, Liver research.
[38] M. Papp,et al. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients , 2020, World journal of gastroenterology.
[39] Yun-fei Yuan,et al. Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma , 2020, Theranostics.
[40] Francisco Castillo,et al. Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein , 2020, Cells.
[41] Jhin Jieh Lim,et al. JAK/STAT signaling in hepatocellular carcinoma , 2020, Hepatic oncology.
[42] Wenjie Zheng,et al. Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation. , 2020, Hepatobiliary & pancreatic diseases international : HBPD INT.
[43] Zhi Chen,et al. c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment , 2019, Oncogenesis.
[44] B. Ren,et al. Metabolic regulation of gene expression by histone lactylation , 2019, Nature.
[45] C. Yen,et al. CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity , 2019, Cell Death & Differentiation.
[46] P. Bose,et al. Advances in early diagnosis of hepatocellular carcinoma , 2019, Hepatoma Research.
[47] Yanhong Zhang,et al. Tumor Microenvironment Regulation by the Endoplasmic Reticulum Stress Transmission Mediator Golgi Protein 73 in Mice , 2019, Hepatology.
[48] Yi Lv,et al. Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma , 2019, Journal of Translational Medicine.
[49] Xiaohui Ye,et al. A meta-analysis of the prognostic significance of Golgi protein 73 in hepatocellular carcinoma in Chinese patients , 2019, Archives of medical science : AMS.
[50] M. Zheng,et al. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer , 2019, Cell Death & Disease.
[51] Yu Chen,et al. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma , 2019, Anti-cancer drugs.
[52] Paul J. Hoffman,et al. Comprehensive Integration of Single-Cell Data , 2018, Cell.
[53] Robert J. Griffin,et al. Consensus guidelines for the use and interpretation of angiogenesis assays , 2018, Angiogenesis.
[54] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[55] Hui-ni Wu,et al. GP73 level determines chemotherapeutic resistance in human hepatocellular carcinoma cells , 2018, Journal of Cancer.
[56] Honggang Zhou,et al. Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma , 2017, Molecular Cancer.
[57] X. Wang,et al. GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis. , 2016, Cancer cell.
[58] Hong Zhang,et al. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice. , 2015, Gastroenterology.
[59] B. Zhu,et al. CXCL10 Decreases GP73 Expression in Hepatoma Cells at the Early Stage of Hepatitis C Virus (HCV) Infection , 2013, International journal of molecular sciences.
[60] D. Hanahan,et al. Modes of resistance to anti-angiogenic therapy , 2008, Nature Reviews Cancer.
[61] Zhong Chen,et al. STAT3: A critical transcription activator in angiogenesis , 2008, Medicinal research reviews.
[62] D. Ribatti,et al. The role of microenvironment in tumor angiogenesis , 2008, Genes & Nutrition.
[63] A. Linstedt,et al. Endosomal Trafficking and Proprotein Convertase Cleavage of cis Golgi Protein GP73 Produces Marker for Hepatocellular Carcinoma , 2007, Traffic.